MCM
CTSO icon

MAI Capital Management’s Cytosorbents Corp CTSO Stock Holding History

MAI Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-233
Closed -$132 – 2656
2026
Q1 		$132 Hold
233
– – ﹤0.01% 4704
2025
Q4 		$149 Hold
233
– – ﹤0.01% 4104
2025
Q3 		$218 Hold
233
– – ﹤0.01% 3702
2025
Q2 		$299 Hold
233
– – ﹤0.01% 3828
2025
Q1 		$233 Buy
233
+130
+126% +$137 ﹤0.01% 3304
2024
Q4 		$94 Buy
+103
New +$101 ﹤0.01% 3429

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

MAI Capital Management's CTSO Position: Q2 2026 in Review

MAI Capital Management sold out of Cytosorbents Corp (CTSO) in Q2 2026, closing a stake of 233 shares — an estimated $132 sold.

MAI Capital Management first reported a position in CTSO in Q4 2024 and held it in 6 quarters. The position peaked at $299 in Q2 2025. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • MAI Capital Management reported no remaining Cytosorbents Corp position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 233 Cytosorbents Corp shares in Q2 2026, an estimated $132.
  • MAI Capital Management first reported a position in Cytosorbents Corp in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Cytosorbents Corp position peaked at $299 in Q2 2025.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.